There’s an app for... problem gamblingNew tools aim to reduce or stop harmful activity through self-monitoring Physiotherapists, psychologists to prescribe in AustraliaMDs fear proposal jeopardizes patient safety Saphris: new atypical antipsychotic New drug indicated for treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar I disorder. Depressed heart patients recover more slowly from exercise Sympathetic dysregulation may help explain worse outcomes in these patients Champix may help reduce alcohol consumption Smoking-cessation drug varenicline (marketed as Champix in Canada) may have potential as a means of reducing alcohol consumption Clinical Notes: Guidelines for monitoring atypical antipsychotics in children Group issues three sets of recommendations concerning the monitoring and management of adverse effects. Mental Health Feature: Depression in youth Treatment, current controversies and the pharmacist’s role. Self-care cognitive behavioural therapy reduces depression severity Patients with chronic illness who used self-management tools showed noticeable improvement ECT credentialling process planned for Canadian MDs Training would build on CPA workshop First atypical antipsychotic approved for adolescents Abilify now indicated for treatment of schizophrenia in adolescents 15–17 years of age. First Previous 56 57 58 59 60 Next Last
